Amarna Therapeutics Appoints Kite Pharma veteran Dr. Markwin Velders to its Supervisory Board
Amarna Therapeutics, a Dutch privately held biotechnology company developing next-generation, SV40 based gene-replacement and immunotherapies across many disease areas, today announced the appointment of former VP Operations and Managing Director at Kite Pharma EU, Dr. Markwin Velders to its Supervisory Board. Dr. Velders is presently Chair of HollandBIO - the association of Dutch biotech companies - and brings many years of experience from the biotech industry, specifically in the cell and gene therapy areas.
More DescriptionImage URL
vlrPhone
vlrFilter
vlrMemosProject of very low consumption, radiation and bitrate softphones
Multifunction Audio Filter with Remote Control
App to measure the quality of the voice
More InformationFree the Animation VR
ARPlay to reveal 3D images and 3D models
More Information
WhmSoft Moblog
Copyright (C) 2006-2021 WhmSoft
All Rights Reserved